John Libbey Eurotext

Hépato-Gastro & Oncologie Digestive

MENU

Eosinophilic colitis in adults Volume 25, issue 8, Octobre 2018

  • [1] Jensen ET, Martin CF, Kappelman MD, Dellon ES. Prevalence of eosinophilic gastritis, gastroenteritis, and colitis: Estimates from a national administrative database. J Pediatr Gastroenterol Nutr 2016 ; 62 : 364.
  • [2] Pineton de Chambrun G., Desreumaux P., Colombel J.F. La gastroentérite à éosinophiles. Revue Française d’Allergologie. 2010;50:248-253.
  • [3] Polydorides A.D., Banner B.F., Hannaway P.J. Evaluation of site-specificand seasonal variation in colonic mucosal eosinophils. Hum Pathol. 2008;39:832-836.
  • [4] Matsushita T., Maruyama R., Ishikawa N. The number and distribution of eosinophils in the adult human gastrointestinal tract - a study and comparison of racial and environmental factors. Am J Surg Pathol. 2015;39:521-527.
  • [5] De Brosse C.W., Case J.W., Putnam P.E., Collins M.H., Rothenberg E. Quantity and distribution of eosinophils in the gastrointestinal tract of children. Pediatric and Developmental Pathology. 2006;9:210-218.
  • [6] Turner K.P., Sinkre R.A., Neumann W.L., Genta R.M. Primary colonic eosinophilia and eosinophilic colitis in adults. Am J Surg Pathol. 2017;41:225-233.
  • [7] Goncalves N. Food allergies and eosinophilic gastrointestinal illness. Gastroenterol Clin North Am. 2007;36:75-91.
  • [8] Rothenberg M.E. Eosinophilic gastrointestinal disorders (EGID). Allergy Clin Immunol. 2004;113:11-28.
  • [9] Klein N.C., Hargrive R.L., Sleisenger M.H. Eosinophilic gastroenteritis. Medecine. 1970;49:299-319.
  • [10] Diaz del Arco C, Taxonera C, Estrada Munoz L, David Olivares D, Fernandez Acenero MJ. Eosinophilic colitis: Experience in a large tertiary hospital. Rom J Morphol Embryol 2017 ; 58 : 783-9.
  • [11] Zammit SC, Cachia M, Sapiano K, Gauci J, Montefort S, Ellul P. Eosinophilic gastrointestinal disorder : is it what it seems to be ? Ann Gastroenterol 2018 ; 31 : 475-80.
  • [12] Zhang L., Duan L., Ding S. Eosinophilic gastroenteritis : clinical manifestations and morphological characteristics, a retrospective study of 42 patients. Scand J Gastroenterol. 2011;46:1074-1080.
  • [13] Guajardo J.R., Plotnick L.M., Fende J.M., Collins M.H., Puynam P.E., Rothenberg M.E. Eosinophil-associated gastrointestinal disorders: A world-wide-web based registry. J Pediatr. 2002;141:576-581.
  • [14] Alfadda A.A., Storr M.A., Shaffer E.A. Eosinophilic colitis: An update on pathophysiology and treatment. Br Med Bull. 2011;100:59-72.
  • [15] Ingle S.B., Hinge C.R. Eosinophilic gastroenteritis: An unusual type of gastroenteritis. World J Gastroenterol. 2013;19:5061-5066.
  • [16] Zezos P., Patsiaoura K., Nakos A. Severe eosinophilic infiltration in colonic biopsies predicts patients with ulcerative colitis not responding to medical therapy. Colorectal disease. 2014;16:O420-O430.
  • [17] Torrente F., Barabino A., Bellini T., Murch S.H. Intraepithelial lymphocyte eotaxin-2 expression and perineural mast cell degranulation differentiate allergic/eosinophilic colitis from classic IBD. J Pediatr Gastroenterol Nutr. 2014;59:300-307.
  • [18] Ertugrul I., Ulker A., Turhan N., Dagli U., Sasmaz N. Eosinophilic colitis as an unusual cause of severe bloody diarrhea. Turk J Gastroenterol. 2008;19:54-56.
  • [19] Box J.C., Tucker J., Watne A.L., Lucas G. Eosinophilic colitis presenting as a left-sided colo-colonic intussusception with secondary large bowel obstruction: An uncommon entity with a rare presentation. Am Surg. 1997;63:741-743.
  • [20] Minciu O., Wegmann D., Gebbers J.O. Eosinophilic colitis - an unusual cause of acute abdomen. Case report and literature review. Schweiz Med Wochenschr. 1992;122:1402-1408.
  • [21] Velchuru V.R., Khan M.A., Hellquist H.B., Studley J.G. Eosinophilic colitis. J Gastrointest Surg. 2007;11:1373-1375.
  • [22] Cianferoni A., Spergel J.M. Eosinophilic esophagitis and gastro-enteritis. Curr Allergy Asthma Rep. 2015;15:58.
  • [23] Chen MJ, Chu CH, Lin SC, Shih SC, Wang TE. Eosinophilic gastroenteritis: Clinical experience with 15 patients. World J Gastroenterol 2003 ; 9 : 2813-6.
  • [24] Tan A.C., Kruimel J.W., Naber T.H. Eosinophilic gastroenteritis treated with non-enteric-coated budesonide tablets. Eur J Gastroenterol Hepatol. 2001;13:425-427.
  • [25] Siewert E., Lammert F., Koppitz P., Schmidt T., Matern S. Eosinophilic gastroenteritis with severe protein-losing enteropathy : successful treatment with budesonide. Dig Liver Dis. 2006;38:55-59.
  • [26] Katsinelos P., Pilpilidis I., Xiarchos P. Oral administration of ketotifen in a patient with eosinophilic colitis and severe osteoporosis. Am J Gastroenterol. 2002;97:1072-1074.
  • [27] Pérez-Millán A., Martín-Lorente J.L., López-Morante A., Yu- guero L., Sáez-Royuela F. Subserosal eosinophilic gastroenteritis treated efficaciously with sodium cromoglycate. Dig Dis Sci. 1997;42:342-344.
  • [28] Moots R.J., Prouse P., Gumpel J.M. Near fatal eosinophilic gastroenteritis responding to oral sodium chromoglycate. Gut. 1988;29:1282-1285.
  • [29] Neustrom M.R., Friesen C. Treatment of eosinophilic gastroenteritis with montelukast. J Allergy Clin Immunol. 1999;104:506.
  • [30] Schwartz D.A., Pardi D.S., Murray J.A. Use of montelukast as steroid-sparing agent for recurrent eosinophilic gastroenteritis. Dig Dis Sci. 2001;46:1787-1790.
  • [31] Quack l, Sellin L., Buchner N.J. Eosinophilic gastroenteritis in a young girl – long term remission under Montelukast. BMC Gastroenterology. 2005;5:24.
  • [32] Redondo-Cerezo E., Cabello M.J., Gonzalez Y., Gomez M., Garcia-Montero M., De Teresa J. Eosinophilic gastroenteritis : our recent experience: one-year experience of atypical onset of an uncommon disease. Scand J Gastroenterol. 2001;36:1358-1360.
  • [33] Prussin C., James S.P., Huber M.M., Klion A.D., Metcalfe D.D. Pilot study of anti-IL-5 in eosinophilic gastroenteritis. J Allergy Clin Immunol. 2003;111:827.
  • [34] Foroughi S., Foster B., Kim N. Anti-IgE treatment of eosinophil-associated gastrointestinal disorders. J Allergy Clin Immunol. 2007;120:594-601.
  • [35] Turner D., Wolters V.M., Russel R.K. Anti-TNF, infliximab, and adalimumab can be effective in eosinophilic bowel disease. J Pediatr Gastroenterol Nutr. 2013;56:492-497.